Does macrocytosis with low hemoglobin and normal iron studies point away from iron deficiency?

In a 55-year-old female presenting with macrocytosis (elevated mean corpuscular volume) and low hemoglobin, normal iron studies—particularly serum ferritin—fundamentally redirect the diagnostic pathway.

Clinical evaluation and diagnostic shift

• Rule out iron deficiency: Normal ferritin levels effectively rule out classic iron-restricted erythropoiesis as the primary driver of anemia, shifting the diagnostic focus.
• Prioritize maturation factors: Clinical guidelines recommend immediate evaluation for vitamin B12 and folate deficiencies.
• Metabolic testing: If serum B12 levels are borderline, measuring functional metabolites like methylmalonic acid (MMA) and homocysteine is critical to confirming a cellular-level deficiency.

Mechanistic pathways

• Impaired DNA synthesis: Deficiencies in vitamin B12 or folate impair purine and thymidylate synthesis, delaying double-stranded DNA replication and nuclear division in erythroid precursors while cytoplasmic maturation proceeds unimpeded. This nuclear-cytoplasmic dyssynchrony produces abnormally large red blood cells.
• Ineffective erythropoiesis: The fragile, poorly matured megaloblasts often undergo premature destruction within the bone marrow. This intramedullary hemolysis releases intracellular iron, which explains why ferritin levels can remain normal or even elevated despite active anemia.

Broader diagnostic considerations

• Non-megaloblastic etiologies: If nutritional markers are normal, macrocytosis directs clinical evaluation toward alternative causes such as hypothyroidism, liver disease, or alcohol use.
• Bone marrow evaluation: Persistent macrocytosis with normal iron, B12, and folate studies raises suspicion for primary bone marrow disorders, notably Myelodysplastic Syndrome (MDS), necessitating hematology referral and bone marrow biopsy.

Bottom line

• In patients presenting with macrocytosis and lower hemoglobin, normal iron studies rule out classic iron deficiency and dictate an immediate diagnostic shift toward evaluating vitamin B12, folate, non-megaloblastic systemic factors, or clonal bone marrow disorders like MDS.